August 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bumble Inc. (“Bumble” or “the Company”) (NASDAQ: BMBL). Investors who purchased Bumble securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Bumble has violated federal… read more
August 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Praxis Precision Medicines, Inc. (“Praxis” or “the Company”) (NASDAQ: PRAX). Investors who purchased Praxis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Praxis has… read more
August 13, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The J. M. Smucker Company (“Smucker” or “the Company”) (NYSE: SJM). Investors who purchased Smucker securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Smucker… read more
August 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Trade Desk, Inc. (“Trade Desk” or “the Company”) (NASDAQ: TTD). Investors who purchased Trade Desk securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
August 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Collective Mining Ltd. (“Collective Mining” or “the Company”) (NYSE: CNL). Investors who purchased Collective Mining securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Collective… read more
August 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Confluent, Inc. (“Confluent” or “the Company”) (NASDAQ: CFLT). Investors who purchased Confluent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Confluent has violated federal… read more
August 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Albany International Corp. (“Albany” or “the Company”) (NYSE: AIN). Investors who purchased Albany securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Albany has violated… read more
August 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exelixis, Inc. (“Exelixis” or “the Company”) (NASDAQ: EXEL). Investors who purchased Exelixis securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Exelixis has violated federal… read more
July 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Simulations Plus, Inc. (“Simulations” or “the Company”) (NASDAQ: SLP). Investors who purchased Simulations securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Simulations has violated… read more
July 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Geely Automobile Holdings Limited (“Geely” or “the Company”) (OTCMKTS: GELYF; GELYY). Investors who purchased Geely securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Geely… read more
July 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ZEEKR Intelligent Technology Holding Limited (“Zeekr” or “the Company”) (NASDAQ: ZK). Investors who purchased Zeekr securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Zeekr… read more
July 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GSK plc (“GSK” or “the Company”) (NYSE: GSK). Investors who purchased GSK securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GSK has violated federal… read more
July 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edgewise Therapeutics, Inc. (“Edgewise” or “the Company”) (NASDAQ: EWTX). Investors who purchased Edgewise securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Edgewise has violated… read more
July 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Proficient Auto Logistics, Inc. (“Proficient Auto” or “the Company”) (NASDAQ: PAL). Investors who purchased Proficient Auto securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
July 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Laser Photonics Corporation (“Laser Photonics” or “the Company”) (NASDAQ: LASE). Investors who purchased Laser Photonics securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Laser… read more
July 13, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Funko, Inc. (“Funko” or “the Company”) (NASDAQ: FNKO). Investors who purchased Funko securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Funko has violated federal… read more
July 11, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Civitas Resources, Inc. (“Civitas” or “the Company”) (NYSE: CIVI). Investors who purchased Civitas securities prior to February 27, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
July 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Compass Diversified Holdings (“Compass” or “the Company”) (NYSE: CODI). Investors who purchased Compass securities prior to March 1, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
July 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of West Pharmaceutical Services, Inc. (“West” or “the Company”) (NYSE: WST). Investors who purchased West securities prior to February 16, 2023, and continue to hold to the present, are encouraged to obtain… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bakkt Holdings, Inc. (“Bakkt” or “the Company”) (NYSE: BKKT). Investors who purchased Bakkt securities prior to March 25, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Open Lending Corporation (“Open Lending” or “the Company”) (NASDAQ: LPRO). Investors who purchased Open Lending securities prior to February 24, 2022, and continue to hold to the present, are encouraged to… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NAPCO Security Technologies, Inc. (“NAPCO” or “the Company”) (NASDAQ: NSSC). Investors who purchased NAPCO securities prior to February 5, 2024, and continue to hold to the present, are encouraged to obtain… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. (“Avis Budget” or “the Company”) (NASDAQ: CAR). Investors who purchased Avis Budget securities prior to February 13, 2024, and continue to hold to the present, are encouraged… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sana Biotechnology, Inc. (“Sana” or “the Company”) (NASDAQ: SANA). Investors who purchased Sana securities prior to March 17, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Solaris Energy Infrastructure, Inc. (“Solaris” or “the Company”) (NYSE: SEI). Investors who purchased Solaris securities prior to July 9, 2024, and continue to hold to the present, are encouraged to obtain… read more
July 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Firsthand Technology Value Fund, Inc. (“Firsthand Technology” or “the Company”) (OTCMKTS: SVVC). Investors who purchased Firsthand Technology securities prior to January 1, 2021, and continue to hold to the present, are… read more
July 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Harrow, Inc. (“Harrow” or “the Company”) (NASDAQ: HROW). Investors who purchased Harrow securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Harrow has violated federal… read more
July 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of National Grid plc (“National Grid” or “the Company”) (NYSE: NGG). Investors who purchased National Grid securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether National… read more
July 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of American Outdoor Brands, Inc. (“American Outdoor” or “the Company”) (NASDAQ: AOUT). Investors who purchased American Outdoor securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
July 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Altimmune, Inc. (“Altimmune” or “the Company”) (NASDAQ: ALT). Investors who purchased Altimmune securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Altimmune has violated federal… read more